Augmentation Patterns Amongst Metformin Initiators with Type 2 Diabetes Mellitus (T2DM)

被引：0
|
作者：
Gopalakrishnan, Chandrasekar [1 ]
Schneeweiss, Sebastian [1 ]
Seeger, John D. [1 ,2 ]
Liu, Jun [1 ]
Patorno, Elisabetta [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA USA
[2] Optum, Epidemiol, Waltham, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
40
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [1] Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients
    Kosmalski, M.
    Drozdowska, A.
    Sliwinska, A.
    Drzewoski, J.
    [J]. ADVANCES IN MEDICAL SCIENCES, 2012, 57 (01): : 65 - 70
  • [2] Safety and Tolerability of Linagliptin and Metformin in Combination for Patients with Type 2 Diabetes Mellitus (T2DM)
    Ross, Stuart A.
    Haak, Thomas
    Patel, Sanjay
    Thiemann, Sandra
    Schumacher, Helmut
    Meinicke, Thomas
    [J]. DIABETES, 2014, 63 : A277 - A277
  • [3] The Usage of Metformin Despite of Existing Contraindications in Type 2 Diabetes Mellitus (T2DM) Patients
    Kosmalski, Marcin
    Drozdowska, Agata
    Drzewoski, Jozef
    [J]. DIABETES, 2011, 60 : A311 - A312
  • [4] Dynamic Channeling among Initiators of a Recently Marketed Medication for Type 2 Diabetes Mellitus (T2DM)
    Patorno, Elisabetta
    Gopalakrishnan, Chandrasekar
    Zorina, Olesya I.
    Schneeweiss, Sebastian
    Bartels, Dorothee B.
    Liu, Jun
    Seeger, John D.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 565 - 566
  • [5] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [6] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [7] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [8] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    [J]. FASEB JOURNAL, 2002, 16 (04): : A208 - A208
  • [9] Retrospective study of type 2 diabetes mellitus (T2DM) patients not optimally controlled by metformin monotherapy
    He, J.
    Neslusan, C.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A18 - A18
  • [10] The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)
    Hayder M. Al-kuraishy
    Ali I. Al-Gareeb
    Hebatallah M. Saad
    Gaber El-Saber Batiha
    [J]. Inflammopharmacology, 2023, 31 : 1751 - 1760
12345